Prediction for the development of preeclampsia through non-invasive hemodynamics using machine learning,

D Olano1, W Espeche2, J Minetto2

  • 1Cardiometabolic Diseases Unit, San Martín Hospital of La Plata, Buenos Aires, Argentina.

PubMed

Insights

Impedance cardiography (ICG) and machine learning accurately predict preeclampsia (PE) risk in high-risk pregnancies. The AI model identified novel hemodynamic patterns, distinguishing early- from late-onset PE with 95% accuracy.

Area of Science:

  • Cardiovascular Physiology
  • Maternal-Fetal Medicine
  • Biomedical Engineering

Background:

  • Preeclampsia (PE) and hypertensive disorders of pregnancy (HDP) are significant causes of maternal and fetal complications, including prematurity.
  • Classification into early- and late-onset PE is based on gestational timing and impacts management.
  • Non-invasive hemodynamic assessment offers a promising avenue for early risk stratification.

Purpose of the Study:

  • To evaluate impedance cardiography (ICG) for non-invasive hemodynamic assessment in predicting early- versus late-onset PE risk.
  • To develop a machine learning model for identifying novel hemodynamic patterns associated with PE.
  • To differentiate between early- and late-onset PE using advanced predictive analytics.

Main Methods:

  • Utilized the J48 classification tree algorithm, a machine learning technique, to build a predictive model.
  • Assessed hemodynamic parameters in 405 high-risk pregnant patients (17-33 weeks gestation) using ICG.
  • Explored non-traditional hemodynamic variables beyond conventional metrics for PE prediction.

Main Results:

  • The machine learning model achieved 95% accuracy in correctly classifying high-risk pregnancies that developed PE.
  • The model successfully distinguished between early-onset and late-onset PE cases.
  • Identified key hemodynamic variables related to contractility, cardiovascular performance, and afterload.

Conclusions:

  • Non-invasive hemodynamic assessment using ICG, coupled with AI, shows significant potential for early PE detection in high-risk pregnancies.
  • The developed model offers improved risk prediction and could advance clinical management strategies for PE.
  • External validation is recommended to further confirm the model's robustness and generalizability.